CION Ameerpet
Explained · Reviewed by CION Oncologists · NABH Accredited
Can You Get Cervical Cancer Without HPV?
Yes — but it is uncommon. WHO puts the proportion of cervical cancers linked to high-risk human papillomavirus at around 99%, which leaves a small remainder that arises another way. Some of those are genuinely HPV-independent tumours, recognised as separate entities in the WHO classification of female genital tumours. Others are HPV-driven cancers in which the test simply read negative — because of how the sample was taken, which virus types the test covers, or how the tumour changed as it grew. Both possibilities matter for the same practical reason: a negative HPV test lowers your risk substantially, but it is not a reason to ignore a symptom.
- Around 99% are HPV-linked — WHO's figure; the exceptions are real but a small minority
- HPV-independent types exist — gastric-type, clear cell, mesonephric and endometrioid cervical tumours
- A negative test can be a false negative — sampling, test panel and tumour biology all play a part
- Symptoms still need examining — bleeding after sex or after menopause, whatever your last result said
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Why the HPV Link Is So Strong — and Where It Ends
Cervical cancer is unusual among cancers in having a single dominant cause that can be tested for. Persistent infection with a high-risk HPV type drives the great majority of cases: the virus switches off the controls that keep cervical cells in order, abnormal cells accumulate over years, and a proportion of those eventually become invasive. That sequence is the reason screening works at all — it gives a decade or more of warning. If you want the mechanism explained end to end, read how a common virus leads to cervical cancer.
That link is so strong that for years HPV-negative cervical cancer was assumed to be a laboratory error. It is now understood differently. The WHO classification of female genital tumours divides both cervical squamous carcinoma and cervical adenocarcinoma into HPV-associated and HPV-independent categories, because pathologists can identify tumours with a distinct appearance, a distinct molecular profile and a distinct clinical behaviour that do not carry the virus at all.
Two different things get called “cervical cancer without HPV”
It is worth separating them, because they lead to different conversations. The first is a truly HPV-independent tumour — a cancer that never involved the virus. The second is an HPV-driven cancer that tested negative, which is a testing question, not a biology question. Most reported HPV-negative cases in older studies belong to the second group. The genuinely HPV-independent tumours are a smaller and better-defined set.
Why this is not a reason to skip screening: the rarity works in the opposite direction to how it feels. Because HPV-independent tumours are uncommon, screening still prevents the overwhelming majority of cervical cancers. What the exceptions change is the follow-up rule, not the screening rule — a symptom deserves examination even when your last HPV test was clear. Read the cervical cancer overview for how screening and symptoms fit together.
Did You Know? Cervical cancer is the only common cancer with a cause identified precisely enough to build a global elimination strategy around it. WHO states that almost all cervical cancer cases — around 99% — are linked to infection with high-risk HPV types, which is why its elimination strategy rests on vaccination and screening rather than on early detection alone. The small non-HPV remainder is the reason symptom awareness stays part of the plan. Sources: WHO cervical cancer fact sheet; WHO Global Strategy for Cervical Cancer Elimination.
The Cervical Cancers That Are Genuinely Not Caused by HPV
These are recognised entities with their own diagnostic criteria. All are rare. A pathologist distinguishes them from the common HPV-associated tumours using appearance under the microscope plus immunohistochemical staining.
Best known
Gastric-Type Adenocarcinoma
The most frequently encountered HPV-independent cervical cancer. It arises from glandular cells that resemble stomach lining, sits higher in the cervical canal where a screening brush may not reach, and often produces a watery discharge rather than the classic contact bleeding. A minority arise in women with Peutz-Jeghers syndrome.
Rare
Clear Cell Adenocarcinoma
A distinct tumour type historically associated with exposure to diethylstilbestrol before birth, though most cases today occur without that history. It can present in younger women and does not follow the usual HPV precancer sequence. Read about clear cell cervical cancer.
Rare
Mesonephric Carcinoma
Arises from remnants of embryonic ducts that persist in the wall of the cervix. It is HPV-independent by definition, usually located deep rather than on the surface, and is diagnosed on the basis of its architecture and staining pattern rather than by any screening test.
Rare
Endometrioid & Other Adenocarcinomas
A group of glandular tumours of the cervix that do not carry HPV. Part of the pathologist's job here is deciding whether the cancer truly started in the cervix or spread down from the uterus, because that distinction changes staging and therefore treatment.
Very rare
Non-Epithelial Tumours
Sarcomas, lymphomas and melanomas can occasionally arise in the cervix. These are not cervical carcinoma at all and have nothing to do with HPV — they are separate diseases that happen to occupy the same organ, and they are treated according to their own guidelines.
Not primary disease
Cancer That Spread to the Cervix
Occasionally a tumour found in the cervix originated elsewhere — most often the uterus, less often the ovary, bowel or breast. It will test HPV-negative because it was never a cervical cancer. Identifying this correctly matters enormously, because the treatment is that of the original cancer.
Because none of these begins as HPV-driven precancer, HPV-based screening is a less reliable safety net for them. That is precisely why persistent symptoms are investigated on their own merit.
When “HPV-Negative” Means the Test Missed It
Before concluding that a cancer is HPV-independent, pathologists and oncologists work through the ordinary explanations. A negative HPV result is not the same as an absence of virus, and there are several well-recognised reasons the two can differ.
1. The sample did not reach the tumour
A cervical brush samples the surface and the lower canal. A tumour sitting high in the endocervical canal, or one buried beneath normal-looking surface tissue, can be missed altogether. This is the commonest reason a woman with a cervical cancer has a normal-looking screening history, and it is an argument for examining a symptom rather than trusting a test taken months earlier.
2. The test only looks for certain types
HPV assays are designed around the types that cause most disease — HPV 16 and HPV 18 above all, plus a defined panel of other high-risk types. A rarer high-risk type outside the panel will not be reported. The result is accurate for what it tested; it was simply not asked the right question.
3. The virus is present but hard to detect
As some tumours progress, viral DNA integrates into the cell's own genome and parts of it can be lost, leaving very little for the test to find. Extensive bleeding, necrosis or inflammation in the sample can also interfere. Both produce a genuinely negative report in a genuinely HPV-driven cancer.
4. The sample was inadequate
Too few cells, a sample taken during heavy bleeding, or degradation in transport all cause unreliable results. A good laboratory flags an inadequate sample rather than reporting it as negative — which is one reason it is worth knowing where your test was processed.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
A Report Is Not an Explanation
Bring your HPV, Pap or biopsy report and have an oncologist tell you what it means for you specifically. Same-week appointments across 7 NABH-accredited Hyderabad locations.
How an HPV-Independent Cervical Cancer Is Identified
No blood test and no screening test names these tumours. They are identified in the laboratory, on tissue, by a pathologist who is specifically looking for the features that separate them from ordinary HPV-associated disease.
Step 1 — The biopsy, and enough of it
Diagnosis begins with tissue from the abnormal area, taken at colposcopy or, where the lesion is high in the canal, by a deeper sampling procedure. Because several of the HPV-independent types sit above the reach of a routine brush, an adequate biopsy is more important here than anywhere else in cervical pathology.
Step 2 — Appearance under the microscope
Each type has a recognisable architecture: gastric-type glands look like stomach lining, clear cell tumours have their characteristic cleared-out cytoplasm, mesonephric tumours form small ducts deep in the cervical wall. An experienced pathologist can often suspect the diagnosis at this stage.
Step 3 — Immunohistochemistry and HPV testing on the tissue
Staining patterns are then used to confirm it. In HPV-associated tumours, a particular staining pattern reflects the virus switching off the cell's control proteins; HPV-independent tumours show a different pattern, and HPV testing performed on the tumour tissue itself — not on a brush sample — is negative. This combination is what allows the WHO categories to be applied in practice.
Step 4 — Imaging, staging and a team decision
Once the type is established, pelvic MRI and other imaging define the extent of disease and a stage is assigned using the FIGO system, exactly as for HPV-associated cancer. At CION the case then goes to a multidisciplinary tumour board — surgery, radiation and medical oncology together, working to NCCN and ESMO guidance — before any plan is proposed.
If you have been given this diagnosis: ask for the exact histological type and whether the report classifies the tumour as HPV-associated or HPV-independent. Those two lines shape the discussion that follows. A review of the original slides is reasonable to request — these are uncommon tumours, and a second pathological opinion is a normal part of good practice, not a criticism of the first.
Why a Cervical Cancer Can Test HPV-Negative
Every row here is a real explanation an oncologist considers before calling a tumour HPV-independent. Most negative results turn out to be one of the first four.
| Reason | What it actually means | What is done about it |
|---|---|---|
| Sampling missed the lesion | The tumour sits high in the canal or beneath normal-looking tissue | Direct examination and a deeper biopsy rather than repeating the brush test |
| Type outside the test panel | A rarer high-risk type the assay does not report | HPV testing performed directly on the tumour tissue |
| Viral DNA integrated or partly lost | Very little detectable virus remains in an advanced tumour | Immunohistochemistry on the tissue to establish the tumour's biology |
| Inadequate or degraded sample | Too few cells, heavy bleeding, or transport delay | Repeat sampling under direct vision, ideally not during a bleed |
| Gastric-type adenocarcinoma | A genuinely HPV-independent glandular tumour | Confirmed on tissue; staged and planned by the tumour board |
| Clear cell or mesonephric carcinoma | Rare HPV-independent types with their own diagnostic criteria | Specialist pathology review, then FIGO staging as usual |
| Sarcoma, lymphoma or melanoma of the cervix | Not cervical carcinoma at all — a different disease in the same organ | Treated to its own guideline, not the cervical cancer pathway |
| Spread from another primary site | The cancer began elsewhere, most often the uterus | Treatment follows the original cancer, so identifying it correctly is critical |
Whatever the type, the treatment building blocks are the same family of options — surgery, radiation with brachytherapy, and systemic therapy, chosen by stage and by tumour biology. Our cervical cancer treatment in Hyderabad page sets out how a plan is decided.
Did You Know? The distinction is now formal, not academic. The current WHO Classification of Tumours of the Female Genital Tract separates cervical squamous cell carcinoma and adenocarcinoma into HPV-associated and HPV-independent categories, because the two groups differ in how they arise, how they look under the microscope and how they behave. It is the reason a modern pathology report may state the HPV status of the tumour itself, separately from any screening test you had. Source: WHO Classification of Tumours, Female Genital Tumours (5th edition).
What This Means for Your Screening — and for a Symptom You Are Ignoring
The existence of HPV-independent cervical cancer is often quoted online as a reason to distrust HPV testing. That is the wrong conclusion to draw. HPV-based screening prevents the overwhelming majority of cervical cancers, and no other test comes close. What the exceptions justify is a single practical rule, and it is worth stating plainly.
A negative HPV test tells you your risk over the next few years is low. It does not tell you that a symptom you have today is harmless. Bleeding after sex, any bleeding after the menopause, a persistent watery or foul-smelling discharge, or pelvic pain that will not settle deserve an examination on their own account — regardless of what your last screening test said, and regardless of how recent it was. Gastric-type adenocarcinoma in particular tends to announce itself as a watery discharge rather than as contact bleeding, which is exactly the symptom women most often put down to infection.
Two further points follow. Vaccination remains as valuable as ever, because it targets the HPV types responsible for nearly all cervical cancer — the rare HPV-independent tumours were never going to be prevented by any vaccine, and their existence does not weaken the case for one. And screening should continue on schedule even in a vaccinated woman, for the same reason.
If your report has already named a specific type, the details matter to you more than the general picture does. Bring it in. Understanding whether a tumour is HPV-associated or HPV-independent, and at what stage it was found, is where a useful conversation about treatment actually starts.
Why Women in Hyderabad Bring Uncommon Diagnoses to CION
Rare tumour types are exactly where a second opinion and a team decision earn their keep.
Free second opinion on pathology
Tumour board for every cancer diagnosis
On-site colposcopy and biopsy
45-minute detailed consultation
Woman doctor available on request
7 NABH-accredited Hyderabad locations
Transparent, itemised costs
EMI facility & insurance accepted
4.8 / 5 Google rating
Take The Next Step
Get the Type Named, Not Guessed
Whether you are trying to make sense of a negative test or a rare diagnosis, one appointment with an oncologist replaces a great deal of searching.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Cervical Cancer Without HPV — Frequently Asked Questions
My HPV test was negative. Can I still develop cervical cancer?
It is possible, but your risk is low — which is exactly what a negative high-risk HPV test is designed to tell you. Two situations account for the exceptions. A small number of cervical cancers are genuinely HPV-independent, such as gastric-type adenocarcinoma, and would never have been flagged by an HPV test. Separately, a test can read negative when the virus is present, usually because the sample did not reach a tumour sitting high in the cervical canal. The practical rule that covers both is simple: continue screening on schedule, and have any persistent symptom examined rather than measured against your last result.
What does it mean if my pathology report says HPV-independent?
It means the pathologist has examined the tumour tissue itself — not a screening sample — and concluded that the cancer arose without human papillomavirus. The current WHO classification formally separates cervical carcinomas into HPV-associated and HPV-independent groups, because they differ in how they develop, how they appear under the microscope and how they behave. The label is descriptive, not a verdict. It does tell your team that the tumour may behave differently from the common HPV-driven type, which is one reason these cases are reviewed carefully by a multidisciplinary tumour board before a treatment plan is agreed.
Are HPV-negative cervical cancers more serious than HPV-positive ones?
They can be more difficult, and it is honest to say so, but the picture is not uniform. HPV-independent tumours do not arise from the precancerous changes that screening detects, so they are more often found because of symptoms and therefore at a later stage. Some types, including gastric-type adenocarcinoma, are also recognised as behaving less predictably. What matters most for any individual woman remains the stage at diagnosis and how completely the treatment plan can be delivered. Outcomes are discussed case by case with your oncologist, not predicted from the HPV status line alone.
Does an HPV-negative tumour change how the cancer is treated?
The building blocks are the same. Cervical cancer is staged using the FIGO system regardless of HPV status, and treatment is drawn from the same options — surgery for early disease, radiation combined with brachytherapy and platinum-based chemotherapy for locally advanced disease, and systemic therapy where the disease has spread. What HPV-independent status can change is the emphasis: the extent of surgery, the imaging used to define spread, and whether newer treatment approaches are appropriate. This is why these cases go through a tumour board rather than being managed by any single specialist.
If HPV does not cause every case, is there any point in the vaccine or in screening?
Yes, and strongly so. WHO puts the proportion of cervical cancer linked to high-risk HPV at around 99%, so vaccination and screening between them address almost the entire disease burden. The rare HPV-independent tumours were never preventable by a vaccine, and their existence does not reduce the benefit that vaccination and screening deliver for everything else. What the exceptions add is a habit rather than a doubt: keep screening on schedule, and treat a persistent symptom as something to be examined, not something to be checked against your last result.
Medical disclaimer: This page is general health information, reviewed by a CION oncologist. It is not a diagnosis and cannot replace an examination. A negative HPV test does not rule out a symptom — if you are bleeding abnormally or have a persistent discharge, please see a doctor rather than relying on any website.